Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Spotlight on Na+/H+-exchange inhibitors

Sep. 3, 1997

HRT and cardiovascular disease in women

Sep. 2, 1997

Gene therapy for cardiovascular diseases

Sep. 2, 1997

Link between high blood pressure and cancer debated

Sep. 2, 1997

Zambon discovers potent and selective NEP inhibitors

Sep. 2, 1997

Final results of BENESTENT-II trial presented

Sep. 2, 1997

Milrinone analogues as novel inotropic agents

Sep. 2, 1997

New therapeutic action of aspirin reported by British researchers

Sep. 2, 1997

Past, present and future of arrhythmia therapy

Sep. 1, 1997

Cardiovascular benefits of the Mediterranean diet

Sep. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...